What are the recent trends in market size and growth for the neurological disorder diagnostics market?
The neurological disorder diagnostics market size has grown strongly in recent years. It will grow from $11.75 $ billion in 2024 to $12.61 $ billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increase in prevalence of neurological disorders, increase in ageing population, growth in emphasis on early diagnosis and disease management, growth in awareness of neurological disorders, and increase focus on early diagnosis.
The neurological disorder diagnostics market size is expected to see strong growth in the next few years. It will grow to $16.6 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growing awareness and education, increasing healthcare expenditure, improved access to healthcare services, expansion of diagnostic centers, and rising adoption of personalized medicine. Major trends in the forecast period include advancements in neuroimaging techniques, adoption of wearable devices and remote monitoring technologies, advancements in biomarker discovery and genetic testing, integration of artificial intelligence and machine learning, and development of point-of-care diagnostic devices.
Get Your Free Sample of The Global Neurological Disorder Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19611&type=smp
How have varous drivers impacted the growth of the neurological disorder diagnostics market?
The increasing prevalence of Alzheimer’s disease is expected to propel the growth of the neurological disorder diagnostics market going forward. Alzheimer’s disease refers to a progressive neurodegenerative disorder characterized by a gradual decline in cognitive functions, including memory, reasoning, and problem-solving. Alzheimer’s disease combines genetic factors, such as specific gene mutations and variations, the accumulation of amyloid plaques and tau tangles in the brain, chronic inflammation, vascular issues, and lifestyle factors. Neurological disorder diagnostics help Alzheimer’s disease by enabling early and accurate detection through advanced imaging techniques, biomarker analysis, and cognitive assessments. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, approximately 411,100 individuals in Australia were living with dementia, including around 257,500 women and 153,700 men. Thus, the increasing prevalence of Alzheimer’s disease is driving the growth of the neurological disorder diagnostics market.
What are the primary segments of the neurological disorder diagnostics market?
The neurological disorder diagnosticsmarket covered in this report is segmented –
1) By Component: Instruments, Reagents, Kits, Software, Services
2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques
3) By Disease Type: Alzheimer’s Disease, Dementia, Parkinson’s Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types
4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,
2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents
3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders
4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software
5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services
Order your report now for swift delivery
Which firms are leading the neurological disorder diagnostics market?
Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
How will industry trends affect the trajectory of the neurological disorder diagnostics market?
Major companies operating in the neurological disorder diagnostics market are focused on developing innovative solutions, such as neurological disease quantification software, for one billion individuals affected by neurological diseases worldwide. Neurological disease quantification software is a tool used to measure and analyze brain function and disease progression in neurological conditions. For instance, in January 2024, Quibim, a Spain-based biotechnology company, launched the QP-Brain, an AI-based early-stage neurological disease quantification software. QP-Brain by Quibim is advanced neuroimaging analysis software designed to quantify brain tissue alterations in neurological diseases. Its unique features include AI-powered automated segmentation and detailed volumetric analysis, offering precise insights into brain structure changes for clinical and research applications.
Which geographic trends are shaping the neurological disorder diagnostics market, and which region has the highest market share?
North America was the largest region in the neurological disorder diagnostics market in 2024. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Neurological Disorder Diagnostics Market Report 2025 Offer?
The neurological disorder diagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Neurological disorder diagnostics refer to the various methods and technologies used to identify, assess, and monitor diseases affecting the nervous system, including the brain, spinal cord, and nerves. These diagnostics involve advanced imaging techniques, biomarker analysis, genetic testing, and cognitive assessments to detect abnormalities, determine disease presence and progression, and guide treatment strategies for neurological conditions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19611
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
